RET and medullary thyroid gland carcinoma: In vitro studies suggest that RET S649L has a low aggressive potential in MTC – despite leading to an increase in kinase activity, cells harboring RET S649L showed a lower proliferation rate compared to those with RET C634R, a more prominent RET mutation (56).